|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Imatinib Mesylate for Targeting
the Platelet-Derived Growth Factor Beta Receptor in Combination
with Fluorouracil and Leucovorin in Patients with Refractory
Pancreatic, Bile Duct, Colorectal, or Gastric Cancer-A Dose-Escalation
Phase I Trial Cancer. 2007 Mar 20. PMID: 17377918 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |